Pacific Edge chief executive David Darling said the Dunedin laboratory had been assessed and cleared for accreditation from International Accreditation New Zealand (IANZ), and was expecting to become certified in about six weeks.
''The IANZ certification is very important for us. It's something countries in Southeast Asia identify with,'' he said.
When asked what the company's plans were for that region, he said there was an ''evaluation'' under way, but would not comment further.
At present the Dunedin laboratory, under other accreditation, has one laboratory technician, but has the capacity to be ramped up to ''triple-shift'' testing during an 18-hour period, which could employ up to eight people, Mr Darling said.
Pacific Edge's diagnostics New Zealand quality manager Lisa Cambridge said IANZ accreditation of the Dunedin laboratory would provide national and international quality recognition and complement US-based CLIA accreditation already gained by the Dunedin laboratory.
''Once obtained we will be able to meet the needs of new commercialisation opportunities that the company may wish to pursue,'' she said in a statement to market.
Mr Darling said the company's main focus remained on building US sales momentum.
''[US] laboratory throughput is tracking to the company's expectations following an active direct sales and marketing programme to clinicians and healthcare organisations.''
